MARC SIZEMORE: Open Payments
NPI 1043419138 · VISALIA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$267 in 14 payments from 7 companies in 2025. Trend: 2023 $760 · 2024 $680 · 2025 $267
Food & beverage: $267
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $86 |
| Otsuka America Pharmaceutical, Inc. | 2 | $48 |
| Lilly USA, LLC | 2 | $35 |
| Novo Nordisk Inc | 2 | $34 |
| Abbott Laboratories | 1 | $27 |
| Verity Pharmaceuticals Inc. | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
Products named: REXULTI, BREZTRI, FARXIGA, MOUNJARO, Rybelsus, FREESTYLE LIBRE 3, Tlando, TRINTELLIX.
Industry payments across CA — which companies pay providers there.
